News | December 06, 2007

Studer Discharge Follow Up Software Sales Hit 100 Hospitals

December 7, 2007 - Studer Group today said its Discharge Call Manager software solution (DCM) has been purchased by 100 hospitals around the country to help improve clinical outcomes and bottom-line results by ensuring staff follows up with patients after discharge and gets quantifiable answers to specific questions.

DCM is a Web-based application that automates the framework of post-discharge calls by auto-populating patient lists, showing customized questions by area and automating results for tracking.

Prior to developing DCM, Studer Group founder Quint Studer examined evidence demonstrating that, among other things, hardwiring discharge calling into the culture of a hospital or healthcare practice reduced readmissions to the hospital within 72 hours, reduced emergency department returns within 24 hours, and dramatically increased patient satisfaction with the hospital experience.

But Studer also found that most healthcare groups were inconsistent in making discharge calls, tracking the information from the calls and generating reports to share information from the calls. The software, DCM, was designed to solve these problems. McCrory oversees installation of the software at hospital sites, helps the hospitals determine which questions to ask and track, and aids the hospitals in aggregating outcomes based on the use of DCM.

DCM works by linking to a hospital's electronic medical records and auto-populating fields so hospital staff can be alerted which patients to follow up with on which day and which questions to ask that patient.

Outcomes from the Studer Group DCM follow-up interviews showed an increased efficiency of the data input process for information from discharge calls rose from zero before implementation of DCM to 71 percent after. The company also claims efficiency of patient call-list generation (targeting which patients to call and when) rose from 5 percent before DCM to 64 percent after.

For more information: www.studergroup.com

Related Content

Canon Medical Receives FDA Clearance for Vantage Orian 1.5T MRI
Technology | Magnetic Resonance Imaging (MRI) | November 15, 2018
Canon Medical Systems USA Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) on its new...
Researchers Awarded 2018 Canon Medical Systems USA/RSNA Research Grants
News | Radiology Imaging | November 13, 2018
The Radiological Society of North America (RSNA) Research & Education (R&E) Foundation recently announced the...
Subtle Medical Showcases Artificial Intelligence for PET, MRI Scans at RSNA 2018
News | Artificial Intelligence | November 13, 2018
At the 2018 Radiological Society of North America annual meeting (RSNA 2018), Nov. 25-30 in Chicago, Subtle Medical...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
Fans of Opposing Soccer Teams Perceive Games Differently

Image courtesy of University of York

News | Neuro Imaging | October 25, 2018
Scientists have scanned the brains of die-hard soccer fans to find out why supporters of rival teams often have very...
IMRIS, Siemens Strengthen Collaboration in Hybrid OR Neurosurgical Market
News | Hybrid OR | October 24, 2018
IMRIS, Deerfield Imaging, in partnership with Siemens Healthineers, announced a strengthened collaboration to advance...
Carotid Artery MRI Improves Cardiovascular Disease Risk Assessment
News | Magnetic Resonance Imaging (MRI) | October 23, 2018
Magnetic resonance imaging (MRI) measurements of wall thickness in the carotid arteries improve cardiovascular disease...
The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

The Elekta Unity with 1.5T MRI embedded as a targeting system appeared at the annual meeting of the American Society of Radiation Oncology (ASTRO) in San Antonio, Texas. The system is being sold in Europe and could soon enter the U.S. marketplace. (Photo courtesy of Elekta)

Feature | ASTRO | October 20, 2018 | By Greg Freiherr
A linear accelerator combined with high-field MRI could soon be on the U.S. market. If U.S.